Cancer Therapy Breakthrough with Claudin 18.2-Targeted Drug Approved in EU
Therapy Milestone: Yipurun’s Drug-Device Combination Secures Approval in China
Bone Marrow Aspiration Advances: SurGenTec’s B-MAN Kit Receives FDA 510(k) Clearance
How Large Language Models and Generative AI Are Transforming MedTech Design
New Service Packages for Special and Incurable Disease Patients in Iran
Aldeyra’s Reproxalap Achieves Milestone in Phase 3 Dry Eye Disease Trial
Join Us for the 2nd Annual ACCESS EU Conference in Barcelona, Spain!
PARP Inhibitors Poised to Revolutionize Cancer Treatment: InsightAce Analytic Market Report
Pharmaceuticals Collaboration Deals Report 2019-2024: Payments, Therapy Focus, and Technology
Patient-Centered Outcomes in Healthcare: Measurement and Impact from Market Access Perspective
The Possible Impact of Digital Twins on Market Access Through Clinical Trials
The Market Access of Supplements in Europe
Top 10 Market Access & HEOR Trends for 2024 and Beyond


